Strides Pharma Science Limited (Strides) a yau ta sanar da cewa ta koma ƙasa gabaɗaya mallakar reshen, Strides Pharma Global Pte. Limited, Singapore, ta sami amincewa ga Tetracycline Hydrochloride Capsules USP, 250 MG da 500 MG daga Hukumar Abinci da Magunguna ta Amurka (USFDA). Samfurin shine nau'in nau'in nau'in Achromycin V Capsules, 250 MG da 500 MG, na Avet Pharmaceuticals Inc (tsohon Heritage Pharmaceuticals Inc.) Bisa ga bayanan IQVIA MAT, kasuwar Amurka don Tetracycline Hydrochloride Capsules USP, 250 MG shine kusan 500 MG. Dalar Amurka miliyan 16 Za a kera wannan samfurin ne a babban ginin kamfanin da ke Bangalore kuma Strides Pharma Inc. zai sayar da shi a kasuwannin Amurka. Kamfanin yana da tarin tarin ANDA guda 123 tare da USFDA wanda 84 ANDAs ya amince da 39 kuma suna jiran amincewa.Tetracycline Hydrochloride. Capsule wani maganin rigakafi ne da ake amfani dashi don magance cututtuka daban-daban na fata, hanji, tsarin numfashi, urinary tract, al'aura, lymph nodes, da sauran tsarin jiki. A wasu lokuta, ana amfani da capsule tetracycline hydrochloride lokacin da penicillin ko wani maganin rigakafi ba za a iya amfani da shi don magance cututtuka masu tsanani kamar Anthrax, Listeria, Clostridium, Actinomyces.Shares of Strides Pharma Science Ltd ya kasance ciniki na ƙarshe a BSE akan Rs.466.65 idan aka kwatanta da kusa kusa da Rs. 437. Jimlar yawan hannun jarin da aka yi ciniki a rana shine 146733 a cikin fiye da 5002. Haɗin ya kai sama da Rs. 473.4 da intraday low na 440. Adadin kuɗin da aka samu a rana shine Rs. 66754491.